David P. Bourdon's most recent trade in LifeStance Health Group Inc was a trade of 205,550 Common Stock done . Disclosure was reported to the exchange on March 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 205,550 | 1,484,271 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 122,994 | 1,330,195 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 09 Mar 2026 | 86,024 | 1,398,247 | - | 6.9 | 594,426 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 09 Mar 2026 | 51,474 | 1,278,721 | - | 6.9 | 355,685 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 09 Mar 2026 | 10,884 | 1,207,201 | - | 6.9 | 75,208 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 395,683 | 1,283,922 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.93 per share. | 05 Mar 2026 | 65,837 | 1,218,085 | - | 6.9 | 456,250 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.11 per share. | 10 Mar 2025 | 10,884 | 888,239 | - | 7.1 | 77,385 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 348,985 | 782,841 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 124,644 | 941,939 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 80,906 | 846,980 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 42,816 | 899,123 | - | 7.6 | 324,973 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 06 Mar 2025 | 29,685 | 817,295 | - | 7.6 | 225,309 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.88 per share. | 06 Mar 2025 | 16,767 | 766,074 | - | 7.9 | 132,124 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 124,644 | 492,682 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 104,022 | 368,038 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.93 per share. | 08 Mar 2024 | 58,826 | 433,856 | - | 6.9 | 407,664 | Common Stock |
| LifeStance Health Grp Inc | David P. Bourdon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 160,256 | 264,016 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 1,250,000 | 1,250,000 | - | - | Stock Option (right to buy) | |
| LifeStance Health Grp Inc | David P. Bourdon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 180,832 | 180,832 | - | 0 | Common Stock | |
| LifeStance Health Grp Inc | David P. Bourdon | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 10 Nov 2022 | 77,072 | 103,760 | - | 5.5 | 426,208 | Common Stock |